These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3769196

  • 1. Abnormalities of circulating immunoreactive pancreatic anionic trypsinogen in cystic fibrosis: an assay artifact due to cross-reacting serum antibodies.
    Moore DJ, Largman C, Kopelman HR, Wong S, Durie PR.
    Clin Biochem; 1986 Oct; 19(5):303-7. PubMed ID: 3769196
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plasma immunoreactive anionic pancreatic trypsin in cystic fibrosis.
    Durie PR, Gaskin KJ, Geokas MC, O'Rourke M, Largman C.
    J Pediatr Gastroenterol Nutr; 1982 Oct; 1(3):337-43. PubMed ID: 7186046
    [Abstract] [Full Text] [Related]

  • 4. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
    Cleghorn G, Benjamin L, Corey M, Forstner G, Dati F, Durie P.
    Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
    [Abstract] [Full Text] [Related]

  • 5. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
    Durie PR, Largman C, Brodrick JW, Johnson JH, Gaskin KJ, Forstner GG, Geokas MC.
    Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elevated serum immunoreactive pancreatic cationic trypsinogen in acute malnutrition: evidence of pancreatic damage.
    Durie PR, Forstner GG, Gaskin KJ, Weizman Z, Kopelman HR, Ellis L, Largman C.
    J Pediatr; 1985 Feb; 106(2):233-8. PubMed ID: 3968610
    [Abstract] [Full Text] [Related]

  • 8. Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis.
    Couper RT, Corey M, Durie PR, Forstner GG, Moore DJ.
    J Pediatr; 1995 Sep; 127(3):408-13. PubMed ID: 7658271
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test.
    Rock MJ, Mischler EH, Farrell PM, Bruns WT, Hassemer DJ, Laessig RH.
    Pediatr Pulmonol; 1989 Sep; 6(1):42-8. PubMed ID: 2704582
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening.
    Sontag MK, Corey M, Hokanson JE, Marshall JA, Sommer SS, Zerbe GO, Accurso FJ.
    J Pediatr; 2006 Nov; 149(5):650-657. PubMed ID: 17095337
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Evaluation of 47,213 infants in neonatal screening for cystic fibrosis, using pancreatitis-associated protein and immunoreactive trypsinogen assays].
    Barthellemy S, Maurin N, Roussey M, Férec C, Murolo S, Berthézène P, Iovanna JL, Dagorn JC, Sarles J.
    Arch Pediatr; 2001 Mar; 8(3):275-81. PubMed ID: 11270251
    [Abstract] [Full Text] [Related]

  • 17. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera.
    Brodrick JW, Geokas MC, Largman C, Fassett M, Johnson JH.
    Am J Physiol; 1979 Nov; 237(5):E474-80. PubMed ID: 91323
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic accuracy of serum cationic trypsinogen estimation for pancreatic diseases.
    Masoero G, Andriulli A, Bianco A, Benitti V, Marchetto M, De La Pierre M.
    Dig Dis Sci; 1982 Dec; 27(12):1089-94. PubMed ID: 7172958
    [Abstract] [Full Text] [Related]

  • 19. Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing.
    Massie J, Curnow L, Tzanakos N, Francis I, Robertson CF.
    Arch Dis Child; 2006 Mar; 91(3):222-5. PubMed ID: 16243854
    [Abstract] [Full Text] [Related]

  • 20. Serum immunoglobulin G directed against porcine trypsin in pancreatic insufficient cystic fibrosis patients receiving pancreatic enzyme supplements.
    Couper R, Lichtman S, Cleghorn G, del Castillo V, Durie P.
    Pancreas; 1991 Sep; 6(5):558-63. PubMed ID: 1946313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.